Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Turkish version of the Hypertonia Assessment Tool for children with motor disorders

Official title: Turkish Translation , Validity and Reliability of the Hypertonia Assessment Tool in Children With Motor Disorders

Run by Kastamonu University · NCT07267442 · Data updated 2026-11-12

This project will test a Turkish translation of the Hypertonia Assessment Tool to see if it works well for children and adolescents with neuromotor disorders such as cerebral palsy.

More Reliability and Validity trials

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment70 (estimated)
SponsorKastamonu University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 10, 2025
Main results expectedJanuary 10, 2026
Study endsJune 10, 2026
Registry record updatedDecember 5, 2025
Trial IDNCT07267442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents under 18 with a diagnosed neuromotor disorder (for example cerebral palsy) who can follow verbal commands and have not had recent botulinum toxin injections, surgery, or medication changes.

Probably not a fit

Children with other active systemic diseases, who cannot follow verbal instructions, or who had recent surgery, botulinum toxin A injections, or medication changes are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project translates the Hypertonia Assessment Tool into Turkish and then measures its reliability and validity in children with neuromotor disorders. Researchers will enroll participants under 18 who can follow verbal commands and who have not had recent botulinum toxin injections, surgery, or medication changes, and will apply the translated tool alongside routine clinical evaluations. Psychometric testing will include inter-rater reliability, test–retest reliability, and comparisons with established measures of tone and motor function. Results will determine whether the Turkish version reliably identifies hypertonia subtypes (spasticity, dystonia, rigidity) and is practical for clinical and research use in Turkey.

Why it matters

Potential benefit: If successful, clinicians in Turkey would have a validated Turkish tool to better identify and characterize abnormal muscle tone, which could improve therapy planning and tracking of treatment effects.

How similar studies have gone: Translations and psychometric validations of hypertonia and tone-assessment tools in other languages have generally shown good reliability and validity, so this approach follows established methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* as voluntary participation in the study,
* a diagnosis of a neuromotor disorder under the age of 18,
* sufficient cognitive ability to follow verbal commands

Exclusion Criteria:

* Patients with any other systemic disease,
* Who had received botulinum toxin A injections or undergone surgery within the past three months,
* Be unable to follow verbal instructions
* Medical treatment had been modified within the last month

Where it's running

  • Gazi University
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.